» Articles » PMID: 24634508

CPEB1 Promotes Differentiation and Suppresses EMT in Mammary Epithelial Cells

Overview
Journal J Cell Sci
Specialty Cell Biology
Date 2014 Mar 18
PMID 24634508
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Downregulation of CPEB1, a sequence-specific RNA-binding protein, in a mouse mammary epithelial cell line (CID-9) causes epithelial-to-mesenchymal transition (EMT), based on several criteria. First, CPEB1 knockdown decreases protein levels of E-cadherin and β-catenin but increases those of vimentin and Twist1. Second, the motility of CPEB1-depleted cells is increased. Third, CID-9 cells normally form growth-arrested, polarized and three-dimensional acini upon culture in extracellular matrix, but CPEB1-deficient CID-9 cells form nonpolarized proliferating colonies lacking a central cavity. CPEB1 downregulates Twist1 expression by binding to its mRNA, shortening its poly(A) tract and repressing its translation. CID-9 cultures contain both myoepithelial and luminal epithelial cells. CPEB1 increases during CID-9 cell differentiation, is predominantly expressed in myoepithelial cells, and its knockdown prevents expression of the myoepithelial marker p63. CPEB1 is present in proliferating subpopulations of pure luminal epithelial cells (SCp2) and myoepithelial cells (SCg6), but its depletion increases Twist1 only in SCg6 cells and fails to downregulate E-cadherin in SCp2 cells. We propose that myoepithelial cells prevent EMT by influencing the polarity and proliferation of luminal epithelial cells in a mechanism that requires translational silencing of myoepithelial Twist1 by CPEB1.

Citing Articles

Long-term severe hypoxia adaptation induces non-canonical EMT and a novel Wilms Tumor 1 (WT1) isoform.

Quenneville J, Feghaly A, Tual M, Thomas K, Major F, Gagnon E Cancer Gene Ther. 2024; 31(8):1237-1250.

PMID: 38977895 PMC: 11327107. DOI: 10.1038/s41417-024-00795-3.


The Roles of Cytoplasmic Polyadenylation Element Binding Protein 1 in Tumorigenesis.

Li J, Wu Y, Zhang D, Zhang Z, Li S, Cheng X Mini Rev Med Chem. 2024; 24(22):2008-2018.

PMID: 38879767 DOI: 10.2174/0113895575293544240605112838.


Cytoplasmic Polyadenylation Element Binding Protein 1 and Atherosclerosis: Prospective Target and New Insights.

Zhou J, Tang C Curr Vasc Pharmacol. 2024; 22(2):95-105.

PMID: 38284693 DOI: 10.2174/0115701611258090231221082502.


CPEB2 Suppresses Hepatocellular Carcinoma Epithelial-Mesenchymal Transition and Metastasis through Regulating the HIF-1α/miR-210-3p/CPEB2 Axis.

You R, Yang Y, Yin G, Jiang H, Lu Y, Gui L Pharmaceutics. 2023; 15(7).

PMID: 37514073 PMC: 10386397. DOI: 10.3390/pharmaceutics15071887.


Re-evaluation of the myoepithelial cells roles in the breast cancer progression.

Shams A Cancer Cell Int. 2022; 22(1):403.

PMID: 36510219 PMC: 9746125. DOI: 10.1186/s12935-022-02829-y.


References
1.
Peinado H, Olmeda D, Cano A . Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat Rev Cancer. 2007; 7(6):415-28. DOI: 10.1038/nrc2131. View

2.
Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, Choi D . Purification and unique properties of mammary epithelial stem cells. Nature. 2006; 439(7079):993-7. DOI: 10.1038/nature04496. View

3.
Reichmann E, Ball R, Groner B, Friis R . New mammary epithelial and fibroblastic cell clones in coculture form structures competent to differentiate functionally. J Cell Biol. 1989; 108(3):1127-38. PMC: 2115403. DOI: 10.1083/jcb.108.3.1127. View

4.
Pandey P, Saidou J, Watabe K . Role of myoepithelial cells in breast tumor progression. Front Biosci (Landmark Ed). 2009; 15(1):226-36. PMC: 2904307. DOI: 10.2741/3617. View

5.
Danielson K, Oborn C, Durban E, Butel J, Medina D . Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro. Proc Natl Acad Sci U S A. 1984; 81(12):3756-60. PMC: 345298. DOI: 10.1073/pnas.81.12.3756. View